Literature DB >> 25640067

Indomethacin-Responsive Patent Ductus Arteriosus in an Extremely Preterm Infant at 8 Weeks Postnatal Age.

Amitoj Singh Chhina1, Bharat Kumar Sharma, Malathi Raja, Mohit Singhal, Arvind Shenoi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25640067     DOI： 10.1007/s12098-015-1693-7

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN： 0019-5456            Impact factor:   1.967


× No keyword cloud information.
  5 in total

Review 1.  Patent ductus arteriosus: pathophysiology and management.

Authors:  E R Hermes-DeSantis; R I Clyman
Journal:  J Perinatol       Date:  2006-05       Impact factor: 2.521

2.  Successful closure of the patent ductus arteriosus by indomethacin in an extremely low birth weight infant of very advanced postnatal age.

Authors:  W Sterniste; C Gabriel; M Sacher
Journal:  Pediatr Cardiol       Date:  1998 May-Jun       Impact factor: 1.655

3.  Age-dependent closure of the patent ductus arteriosus by indomethacin.

Authors:  J S McCarthy; L G Zies; H Gelband
Journal:  Pediatrics       Date:  1978-11       Impact factor: 7.124

4.  Indomethacin therapy in infants with advanced postnatal age and patent ductus arteriosus.

Authors:  B Achanti; T F Yeh; R S Pildes
Journal:  Clin Invest Med       Date:  1986-11       Impact factor: 0.825

Review 5.  Clinical pharmacology of indomethacin in preterm infants: implications in patent ductus arteriosus closure.

Authors:  Gian Maria Pacifici
Journal:  Paediatr Drugs       Date:  2013-10       Impact factor: 3.022
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.